7Baggers

Astera Labs Inc
(NASDAQ:ALAB) 

ALAB stock logo

Astera Labs, Inc. designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. The company is headquartered in Santa Clara, California.

Founded: 2017
Founder: Jitendra Mohan, Sanjay Gajendra, and Casey Morrison 
CEO: Jitendra Mohan  
Sector: TECHNOLOGY
Industry: GENERAL

Share this website to your friends
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
  • Connectivity-Focused Semiconductor Company: Astera Labs Inc designs semiconductor connectivity solutions (often described as high-speed interconnect/retimer and related ICs) aimed at moving data efficiently across modern computing systems.
  • Positioned Around AI/Data Center Infrastructure Demand: The company is commonly associated with enabling bandwidth and signal integrity needs in data centers and accelerated computing, where demand can be driven by AI and cloud buildouts.
  • Exposure to Hyperscaler and OEM Adoption Cycles: Business momentum can be sensitive to customer design wins, platform transitions, and capex cycles at large data-center operators and system OEMs.
  • Competitive, Fast-Moving Market Dynamics: Astera operates in a space with rapid standards evolution and strong competition, making time-to-market, performance, and customer qualification critical.
  • Key Watch Items for Investors: Typical focus areas include revenue growth durability, customer concentration, gross margin profile, operating leverage, and how quickly R&D spend converts into scaled production programs.
Bull Thesis:
  • Critical Enabler of AI Infrastructure Scaling: Astera Labs' PCIe and CXL connectivity solutions are essential for overcoming data bottlenecks and extending reach in AI/ML clusters. The company directly benefits from the explosive growth in AI accelerator deployments and data center build-outs, positioning it as a foundational technology provider for the AI revolution.
  • Pioneering Leadership in CXL Technology: Astera Labs is at the forefront of Compute Express Link (CXL) innovation with its Leo product family. As CXL becomes a standard for memory expansion and pooling in next-generation data centers, Astera is well-positioned to capture significant market share and unlock substantial new revenue streams.
  • Expanding Design Wins with Hyperscalers and AI Leaders: The company has secured critical design wins with leading hyperscale cloud providers and AI chip developers. This indicates strong product validation and integration into key platforms, which should translate into sustained revenue growth as these platforms scale their deployments.
  • Strong IP Portfolio and High Barriers to Entry: Astera Labs possesses a robust intellectual property portfolio in high-speed connectivity, particularly for PCIe and CXL. The complexity and specialized expertise required to develop these solutions create significant barriers to entry for potential competitors, protecting Astera's market position and pricing power.
Bear Thesis:
  • Intense Competition from Established Semiconductor Giants: Astera Labs operates in a highly competitive market against well-capitalized and established semiconductor companies like Broadcom and Marvell. These larger players could exert pricing pressure or develop competing solutions, potentially limiting Astera's market share and margin expansion.
  • Significant Customer Concentration Risk: A substantial portion of Astera Labs' revenue is derived from a limited number of hyperscale cloud providers and AI hardware developers. The loss of a major customer or a significant reduction in their orders could have a material adverse impact on the company's financial performance.
  • Risk of Rapid Technological Obsolescence: The fast-paced evolution of AI and data center technologies, including new interconnect standards or proprietary solutions developed by large customers, poses a risk. Astera Labs' current product portfolio could become obsolete or less competitive over time, requiring continuous and costly R&D.
  • Elevated Valuation Amidst Market Volatility: Following its recent IPO, Astera Labs' valuation appears stretched relative to its current revenue and profitability, especially in a volatile market environment. This high valuation leaves little room for execution missteps or market downturns, potentially leading to significant share price corrections.
Main Competitors:
  • Broadcom Inc. ($AVGO) (PCIe Switches, Custom ASICs, Ethernet Controllers), A diversified semiconductor giant with a strong presence in data center networking, storage, and broadband communication. Broadcom competes with Astera Labs through its extensive portfolio of high-speed interconnect solutions, including PCIe switches and custom ASICs that can integrate or offer alternative solutions for data center connectivity and performance optimization, particularly in large-scale deployments. Their broad customer base and integrated offerings pose a significant competitive force.
  • Rambus Inc. ($RMBS) (CXL Memory Controllers & IP, PCIe IP), Specializes in memory interface chips and IP, security IP, and high-speed interconnect solutions. Rambus is a direct competitor in the CXL (Compute Express Link) space, offering CXL memory controllers and IP that enable memory expansion and pooling, directly competing with Astera Labs' CXL solutions. They also provide PCIe IP, vying for design wins in the high-speed interconnect market.
  • Marvell Technology, Inc. ($MRVL) (Ethernet Controllers, Custom ASICs, Data Center Switches), A leading provider of data infrastructure semiconductor solutions, including networking, storage, and custom ASICs. Marvell competes by offering a broad portfolio of data center connectivity products, including Ethernet controllers, switches, and custom silicon that can integrate or compete with Astera Labs' PCIe and CXL solutions for optimizing data flow and performance in AI/ML workloads. Their comprehensive data center offerings allow them to provide end-to-end solutions.
  • Microchip Technology Inc. ($MCHP) (PCIe Retimers, PCIe Switches, Timing Solutions), Offers a wide range of embedded control solutions, including a significant portfolio of data center products through its acquisition of Microsemi. Microchip competes directly with Astera Labs in PCIe retimers and switches, providing solutions for signal integrity and connectivity extension in high-speed data paths within servers and data centers. Their established presence and broad product catalog in embedded and data center markets make them a formidable competitor.
Moat:
Astera Labs operates in the critical and rapidly growing segment of high-speed data center connectivity, particularly for AI/ML workloads, focusing on PCIe and CXL retimers and controllers. Their competitive moat lies in their specialized expertise, early market entry, and agility in developing solutions for emerging standards like CXL. However, they face robust competition from larger, more diversified semiconductor companies. Broadcom and Marvell leverage their extensive portfolios, deep customer relationships, and significant R&D budgets to offer integrated data center solutions that can encompass or compete with Astera's offerings. Rambus is a more direct competitor in the CXL IP and chip space, while Microchip directly competes in PCIe retimers and switches. Competition revolves around performance, power efficiency, compliance with evolving standards (e.g., PCIe Gen5/Gen6, CXL 2.0/3.0), time-to-market, and strategic partnerships with hyperscalers and CPU/GPU vendors. Astera Labs' success hinges on its ability to maintain technological leadership and secure design wins against these established players.
Income Statements:
Quarterly
Annual
    Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 
             
      revenue
    308,361,000 270,583,000 230,575,000 191,925,000 159,442,000 141,096,000 113,086,000 76,850,000 65,258,000 
      yoy
    93.40% 91.77% 103.89% 149.74% 144.33%     
      qoq
    13.96% 17.35% 20.14% 20.37% 13.00% 24.77% 47.15% 17.76%  
      cost of revenue
    73,220,000 66,108,000 54,763,000 46,362,000 40,031,000 36,648,000 25,209,000 16,996,000 14,738,000 
      gross profit
    235,141,000 204,475,000 175,812,000 145,563,000 119,411,000 104,448,000 87,877,000 59,854,000 50,520,000 
      yoy
    96.92% 95.77% 100.07% 143.20% 136.36%     
      qoq
    15.00% 16.30% 20.78% 21.90% 14.33% 18.86% 46.82% 18.48%  
      gross margin %
    76.26% 75.57% 76.25% 75.84% 74.89% 74.03% 77.71% 77.88% 77.42% 
      operating expenses
             
      research and development
    125,634,000 93,792,000 78,928,000 66,724,000 64,554,000 56,524,000 50,659,000 40,089,000 53,558,000 
      sales and marketing
    21,899,000 20,104,000 19,359,000 18,609,000 21,702,000 22,818,000 23,248,000 22,076,000 55,510,000 
      general and administrative
    25,775,000 23,621,000 22,119,000 20,456,000 21,870,000 24,962,000 22,866,000 22,036,000 24,419,000 
      total operating expenses
    173,308,000 137,517,000 120,406,000 105,789,000 108,126,000 104,304,000 96,773,000 84,201,000 133,487,000 
      operating income
    61,833,000 66,958,000 55,406,000 39,774,000 11,285,000 144,000 -8,896,000 -24,347,000 -82,967,000 
      yoy
    447.92% 46398.61% -722.82% -263.36% -113.60%     
      qoq
    -7.65% 20.85% 39.30% 252.45% 7736.81% -101.62% -63.46% -70.65%  
      operating margin %
    20.05% 24.75% 24.03% 20.72% 7.08% 0.10% -7.87% -31.68% -127.14% 
      interest income
    11,581,000 11,957,000 11,456,000 10,885,000 10,432,000 10,558,000 10,912,000 10,264,000 2,554,000 
      income before income taxes
    73,414,000 78,915,000 66,862,000 50,659,000 21,717,000 10,702,000 2,016,000 -14,083,000 -80,413,000 
      income tax benefit
    -6,896,000         
      net income
    80,310,000 44,982,000 91,114,000 51,219,000 31,819,000 24,713,000 -7,593,000 -7,546,000 -92,995,000 
      yoy
    152.40% 82.02% -1299.97% -778.76% -134.22%     
      qoq
    78.54% -50.63% 77.89% 60.97% 28.75% -425.47% 0.62% -91.89%  
      net income margin %
    26.04% 16.62% 39.52% 26.69% 19.96% 17.52% -6.71% -9.82% -142.50% 
      net income per share
             
      basic
    0.47 0.27 0.54 0.31 0.19     
      diluted
    0.44 0.25 0.5 0.29 0.18     
      weighted-average shares used for eps calculation
             
      basic
    170,726 166,408 167,436 165,428 163,194     
      diluted
    181,157 179,551 180,631 178,100 178,116     
      other comprehensive income
             
      unrealized gain on marketable securities, net of taxes
    -5,090 213 1,223 846 1,602 -4,004 4,782   
      total other comprehensive gain
    -5,090   846 1,602 1,042.75 4,782   
      total comprehensive income
    75,220 45,195 92,337 52,065 33,421     
      income tax provision
     33,933,000 -24,252,000 -560,000 -10,102,000 -14,011,000 9,609,000 -6,537,000 12,582,000 
      net income per share
             
      basic and diluted
         0.25 -0.05 -0.05 -1.77 
      weighted-average shares used for eps calculation
             
      basic and diluted
         131,262 156,831 155,199 52,532 
      other comprehensive loss
             
      total comprehensive loss
         20,709 -2,811 -7,839,000 -93,313,000 
      unrealized losses on marketable securities, net of taxes
           -293,000  
      total other comprehensive loss
           -293,000  
      unrealized gains on marketable securities, net of taxes
            -318,000 
      total other comprehensive income
            -318,000 
    Balance Sheets:
    Quarterly
    Annual
      Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 
               
        assets
               
        current assets
               
        cash and cash equivalents
      148,285,000 167,611,000 140,407,000 162,328,000 86,431,000 79,551,000 126,117,000 421,076,000 696,077,000 
        marketable securities
      1,036,189,000 1,021,205,000 994,021,000 902,758,000 838,295,000 834,750,000 760,684,000 409,919,000 105,314,000 
        accounts receivable
      134,797,000 83,202,000 42,898,000 24,318,000 69,778,000 38,811,000 25,386,000 22,233,000 16,757,000 
        inventory
      60,156,000 58,979,000 51,663,000 58,602,000 51,057,000 43,215,000 24,415,000 28,572,000 29,567,000 
        prepaid expenses and other current assets
      33,509,000 31,033,000 61,170,000 32,742,000 30,258,000 16,652,000 8,987,000 9,445,000 6,725,000 
        total current assets
      1,412,936,000 1,362,030,000 1,290,159,000 1,180,748,000 1,075,819,000 1,012,979,000 945,589,000 891,245,000 854,440,000 
        property and equipment
      97,172,000 92,038,000 72,482,000 62,075,000 39,474,000 35,651,000 35,137,000 21,821,000 7,581,000 
        goodwill
      87,725,000         
        other assets
      61,382,000 77,755,000 38,541,000 28,582,000 6,401,000 5,878,000 2,339,000 2,449,000 2,880,000 
        total assets
      1,659,215,000 1,531,823,000 1,401,182,000 1,271,405,000 1,121,694,000 1,054,508,000 983,065,000 915,515,000 864,901,000 
        liabilities and stockholders’ equity
               
        current liabilities
               
        accounts payable
      55,818,000 42,362,000 25,811,000 31,573,000 29,513,000 26,918,000 18,551,000 14,595,000 11,465,000 
        accrued expenses and other current liabilities
      69,226,000 90,680,000 75,147,000 74,810,000 47,767,000 59,624,000 69,489,000 49,478,000 34,122,000 
        total current liabilities
      125,044,000 133,042,000 100,958,000 106,383,000 77,280,000 86,542,000 88,040,000 64,073,000 45,587,000 
        other liabilities
      40,223,000 35,147,000 28,493,000 29,308,000 2,852,000 3,167,000 5,413,000 6,190,000 10,530,000 
        total liabilities
      165,267,000 168,189,000 129,451,000 135,691,000 80,132,000 89,709,000 93,453,000 70,263,000 56,117,000 
        commitments and contingencies
               
        stockholders’ equity
               
        common stock, 0.0001 par value...
      17,000 17,000 17,000 17,000 16,000 16,000 16,000 16,000 16,000 
        additional paid-in capital
      1,404,063,000 1,348,969,000 1,302,261,000 1,258,581,000 1,216,495,000 1,173,153,000 1,118,675,000 1,071,504,000 1,027,197,000 
        accumulated other comprehensive income
      -780,000 4,310,000 4,097,000 2,874,000 2,028,000 426,000 4,430,000 -352,000 -59,000 
        retained earnings
      90,648,000 10,338,000        
        total stockholders’ equity
      1,493,948,000 1,363,634,000 1,271,731,000 1,135,714,000 1,041,562,000 964,799,000 889,612,000 845,252,000 808,784,000 
        total liabilities and stockholders’ equity
      1,659,215,000 1,531,823,000 1,401,182,000 1,271,405,000 1,121,694,000     
        accumulated deficit
        -34,644,000 -125,758,000 -176,977,000 -208,796,000 -233,509,000 -225,916,000 -218,370,000 
        liabilities, redeemable convertible preferred stock and stockholders’ equity
               
        redeemable convertible preferred stock, 0.0001 par value...
               
        total liabilities, redeemable convertible preferred stock and stockholders’ equity
           1,054,508,000 983,065,000 915,515,000 864,901,000 
               
      Cashflow Statements:
      Quarterly
      Annual
        Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 
                 
          cash flows from operating activities
                 
          net income
        80,310,000 44,982,000 91,114,000 51,219,000 31,819,000     
          adjustments to reconcile net income to net cash from operating activities
                 
          stock-based compensation
        48,913,000 41,374,000 40,739,000 35,474,000 42,446,000 48,218,000 45,535,000 43,067,000 97,768,000 
          depreciation and amortization
        3,710,000 2,846,000 1,466,000 1,392,000 1,125,000     
          non-cash operating lease expense
        1,177,000 643,000 768,000 826,000 696,000 741,000 581,000 584,000 522,000 
          warrants contra revenue
        2,097,000 1,498,000 1,880,000 1,762,000 374,000 449,000 503,000 333,000 110,000 
          accretion of discounts on marketable securities
        -1,202,000 -1,654,000 -1,789,000 -1,947,000 -2,542,000  -3,231,000 -1,071,000 -566,000 
          other
        -1,313,000 -1,472,000 -503,000 1,759,000 -1,025,000     
          changes in operating assets and liabilities:
                 
          accounts receivable
        -51,789,000 -40,254,000 -18,580,000 45,459,000 -30,968,000 -13,426,000 -3,156,000 -5,476,000 -8,422,000 
          inventory
        346,000 -5,844,000 7,471,000 -7,790,000 -6,787,000 -18,016,000 4,699,000 -70,000 -5,900,000 
          prepaid expenses and other assets
        13,889,000 23,003,000 -38,286,000 -3,979,000 -14,495,000 -8,033,000 398,000 -2,730,000 -2,666,000 
          accounts payable
        -699,000 15,282,000 -5,695,000 2,381,000 2,226,000 9,164,000 5,892,000 858,000 4,973,000 
          accrued expenses and other liabilities
        -20,841,000 16,394,000 968,000 10,084,000 -11,676,000 -76,000 20,164,000 706,000 10,224,000 
          net cash from operating activities
        74,598,000 95,265,000 78,171,000 135,366,000 10,504,000 39,703,000 63,508,000 29,813,000 3,652,000 
          capital expenditures
        -7,586,000 -18,689,000 -12,293,000 -2,023,000 -4,539,000 -15,448,000 -16,697,000 1,324,000 -3,424,000 
          free cash flows
        67,012,000 76,576,000 65,878,000 133,343,000 5,965,000 24,255,000 46,811,000 31,137,000 228,000 
          cash flows from investing activities
                 
          purchases of property and equipment
        -7,586,000 -18,689,000 -12,293,000 -2,023,000 -4,539,000 -15,448,000 -16,697,000 1,324,000 -3,424,000 
          purchases of marketable securities
        -156,628,000 -193,321,000 -259,750,000 -213,861,000 -190,821,000 -205,654,000 -379,165,000 -322,448,000 -23,308,000 
          sales and maturities of marketable securities
        137,756,000 168,005,000 171,498,000 152,191,000 191,420,000     
          payments for business combinations, net of cash acquired
        -65,049,000         
          other investing activities
        -2,500,000         
          net cash from investing activities
        -94,007,000 -72,791,000 -101,045,000 -63,693,000 -3,940,000 -91,427,000 -359,419,000 -302,471,000 -4,251,000 
          cash flows from financing activities
                 
          proceeds from exercises of stock options
        82,000         
          net cash from financing activities
        82,000 3,728,000 952,000 4,737,000 386,000 5,651,000 952,000 -2,343,000 651,578,000 
          net increase in cash, cash equivalents, and restricted cash
        -19,327,000 26,202,000 -21,922,000 76,410,000 6,950,000     
          cash, cash equivalents, and restricted cash
                 
          beginning of the period
        167,684,000  80,044,000  45,098,000 
          end of the period
        148,357,000  -21,922,000 76,410,000 86,994,000  -294,959,000 -275,001,000 696,077,000 
          changes in operating assets and liabilities
                 
          operating lease liability
         -1,533,000 -1,382,000 -1,274,000 -689,000 -749,000 -591,000 -624,000 -438,000 
          other investment activities
                 
          proceeds from issuance of common stock in connection with initial public offering, net of underwriting discounts and commissions
             672,198,000 
          payment of deferred offering costs
             -3,045,000 -1,756,000 
          proceeds from employee stock purchase plan
         3,633,000       
          tax withholding related to net share settlements of restricted stock units
             -20,111,000 
          repurchase of common stock upon termination
                 
          beginning of the year
                 
          end of the year
                 
          proceeds from exercises of stock options, net of repurchases
          952,000 392,000 386,000  952,000 702,000 1,247,000 
          supplemental disclosures of cash flow information:
                 
          conversion of redeemable convertible preferred stock into common stock in connection with initial public offering
             255,127,000 
          purchases of property and equipment in accounts payable, accrued expenses and other current liabilities
                 
          right-of-use assets obtained in exchange for lease obligations
              439,000 174,000 231,000 
          property and equipment acquired through tenant improvement allowance
                 
          deferred offering costs included in accounts payable and accrued expenses
                3,045,000 
          net loss
             24,713,000 -7,593,000 -7,546,000 -92,995,000 
          adjustments to reconcile net loss to net cash from operating activities
                 
          depreciation
             974,000 849,000 717,000 614,000 
          inventory write-downs
             -783,000 -542,000 1,065,000 428,000 
          accretion of discounts on marketable securities and other
                 
          proceeds from issuance of redeemable convertible preferred stock, net of issuance costs
                 
          supplemental cash flow information:
                 
          exchange of common stock to series d redeemable convertible preferred stock
                 
          income taxes paid
                 
          maturities of marketable securities
              15,803,000 11,411,000 9,365,000 
          sales of marketable securities
              20,640,000 7,242,000 13,116,000 
          net increase in cash and cash equivalents
              -294,959,000 -275,001,000 650,979,000 
          cash and cash equivalents
                 
          noncash investing and financing activities
                 
          purchases of property and equipment in accounts payable and accrued expenses